№ 1/2022

Volume 15, number 1

 

HEALTHCARE MANAGEMENT

A Rationale for a New Operational Integrated Quality and Efficiency Index for Assessing the Performance of Hematological Services in Constituent Entities of the Russian Federation

Parovichnikova EN, Garmaeva TTs, Lazareva OV, Lukina KA, Chabaeva YuA, Kulikov SM, Troitskaya VV, Gaponova TV, Menshikova LI, Savchenko VG

PDF

pdficon

REVIEWS

Artificial Intelligence in Hematology

Luchinin AS

PDF

pdficon

LYMPHOID TUMORS

Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

Popova MO, Tsygankov IV, Gudozhnikova YaV, Rogacheva YuA, Volkov NP, Lepik KV, Demchenkova MV, Grigoreva MV, Efirkina AYu, Shneider TV, Kopeikina YuV, Stepanova SA, Potapenko VG, Klimovich AV, Medvedeva NV, Kolesnikova MA, Pospelova TI, Mikhailova NB, Baikov VV, Kulagin AD

PDF

pdficon

The Efficacy of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin’s Lymphoma and Quality of Life: Results of a Multi-Center Observational Prospective Study in the Context of Real Clinical Practice

Ionova TI, Amdiev AA, Andrievskikh MI, Baryakh EA, Vasilev EV, Volkov MV, Volodicheva EM, Ivanov VV, Kaverina OV, Kaplanov KD, Klitochenko TYu, Kurakin VI, Lazareva DG, Larionova OG, Lepik KV, Lysenko IB, Melnichenko VYa, Minullina RI, Mironov OV, Misyurina EN, Mikhailova NB, Mochkin NE, Nikitina TP, Petrova TS, Porfireva NM, Rukavitsyn OA, Samoilova AA, Safin RN, Simashova PI, Smirnova EG, Trenina NA, Fadeeva NV, Khusainova GN, Chang VL, Shelekhova TV, Sherstnev DG

PDF

pdficon

MYELOID TUMORS

Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Main Objectives, Design, and Expected Results

Turkina AG, Gurianova MA, Chelysheva EYu, Shukhov OA

PDF

pdficon

The Role of BAALC-Expressing Leukemia Precursor Cells in the Pathogenesis of Myelodysplastic Syndromes

Mamaev NN, Latypova MV, Shakirova AI, Gindina TL, Kanunnikov MM, Tsvetkov NYu, Barkhatov IM, Bondarenko SN, Vladovskaya MD, Morozova EV

PDF

pdficon

Current State of Diagnosis and Treatment of Acute Myeloid Leukemias in Adult Patients in the Republic of Kazakhstan

Klodzinskii AA, Pivovarova IA, Turgunova LG, Anafina AZh, Zinchenko AV

PDF

pdficon

Correlation of the Number of TGFβF1-Expressing Atypical Megakaryocytes with the Degree of Bone Marrow Stroma Fibrosis and Osteosclerosis in Patients with Essential Thrombocythemia and Different Stages of Primary Myelofibrosis

Chebotarev DI, Kovrigina AM, Melikyan AL

PDF

pdficon

Pharmacoeconomic Analysis of Gilteritinib in the Therapy of Adult Patients with Relapsed/Refractory Acute Myeloid Leukemias with FLT3 Mutation

Kolbin AS, Gomon YuM, Balykina YuE, Proskurin MA

PDF

pdficon

BONE MARROW TRANSPLANTATION

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma with Renal Impairment

Firsova MV, Mendeleeva LP, Solov’ev MV, Mironova DA, Kuzmina LA, Savchenko VG

PDF

pdficon

COMPLICATIONS OF CHEMOTHERAPY

Current Aspects in Early Diagnosis of Cardiotoxic Complications of Drug Therapy in Oncology: A Literature Review

Gimatdinova GR, Danilova OE, Davydkin IL, Khairetdinov RK, Rogozina LA

PDF

pdficon

FROM THE EDITORS

From the editors PDF

pdficon